Literature DB >> 12488657

Clinical manifestations of rotavirus infection in the neonatal intensive care unit.

Renu Sharma1, Mark L Hudak, Bangalore R Premachandra, Gary Stevens, Carmela B Monteiro, James A Bradshaw, Andrew M Kaunitz, Robert A Hollister.   

Abstract

OBJECTIVES: This report describes clinical signs of rotavirus infection (RVI) among neonates admitted to a neonatal intensive care unit (NICU), compares these signs between term and preterm neonates and assesses the seasonal distribution of RVI in the NICU with that of the community.
METHODS: After an initial prevalence study of 28 days, a prospective longitudinal study in the NICU was conducted. During the next 48 months from December 1, 1991 to November 30, 1995, term and preterm NICU patients were evaluated daily for pre-defined deviations in their baseline gastrointestinal status. Fecal specimens of neonates who fulfilled the entry criteria were tested for rotavirus by a monoclonal antibody-based enzyme immunoassay and by immunoelectron microscopy. Demographic and outcome data for these neonates were collected. In addition data assessing RVI in the community were collected during this period.
RESULTS: The prevalence of RVI among NICU patients was 18.4%. Of 194 neonates included in the longitudinal study, 95 had RVI. Neonates with RVI differed from those without RVI with respect to frequent stooling (P = 0.0005), higher percentage of bloody mucoid stools (P = 0.003) and higher percentage of watery stools (P = 0.023). The odds of these three clinical outcomes were approximately 2.5 times higher in neonates with RVI than in neonates without RVI. Among neonates included in the study advanced necrotizing enterocolitis occurred at the same rate (15%) among those with and without RVI. Comparisons between term and preterm neonates with RVI showed that frequent stooling (P = 0.003) and watery stools (P = 0.0001) occurred more often among term neonates, whereas bloody mucoid stools (P = 0.001), abdominal distention (P = 0.03) and intestinal dilatation (P = 0.016) were more common in preterm neonates. The seasonal distribution of RVI in NICU paralleled its distribution in the community.
CONCLUSION: RVI appears prevalent in the NICU setting. An absence of watery stools in a neonate should not preclude consideration of RVI when evaluating gastrointestinal signs among neonates. The clinical spectrum of RVI differs in term and preterm infants.

Entities:  

Mesh:

Year:  2002        PMID: 12488657     DOI: 10.1097/00006454-200212000-00003

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  20 in total

Review 1.  [Viral acute diarrhea: clinical and evolutive aspects].

Authors:  J-P Olives; E Mas
Journal:  Arch Pediatr       Date:  2007-10       Impact factor: 1.180

Review 2.  Rotavirus infections and vaccines: burden of illness and potential impact of vaccination.

Authors:  Keith Grimwood; Stephen B Lambert; Richard J Milne
Journal:  Paediatr Drugs       Date:  2010-08-01       Impact factor: 3.022

3.  Rotavirus Vaccination Coverage During a Rotavirus Outbreak Resulting in a Fatality at a Subacute Care Facility.

Authors:  Rachel M Burke; Jacqueline E Tate; George S Han; Rebecca Quenelle; Rashi Gautam; Debra A Wadford; Michael D Bowen; Umesh D Parashar
Journal:  J Pediatric Infect Dis Soc       Date:  2020-07-13       Impact factor: 3.164

Review 4.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

5.  The coincidence of necrotizing enterocolitis and rotavirus infections and potential associations with cytokines.

Authors:  Efsun Sızmaz; Mehmet Satar; Ferda Ozlü; Akgün Yaman; Hacer Yapıcıoğlu Yıldızdaş; Kenan Ozcan
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

Review 6.  Pentavalent human-bovine (WC3) reassortant rotavirus vaccine in special populations: a review of data from the Rotavirus Efficacy and Safety Trial.

Authors:  M Van der Wielen; P Van Damme
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-20       Impact factor: 3.267

7.  Impact of rotavirus vaccine on premature infants.

Authors:  Jean-Michel Roué; Emmanuel Nowak; Grégoire Le Gal; Thomas Lemaitre; Emmanuel Oger; Elise Poulhazan; Jean-Dominique Giroux; Armelle Garenne; Arnaud Gagneur
Journal:  Clin Vaccine Immunol       Date:  2014-07-30

8.  Absence of genetic differences among G10P[11] rotaviruses associated with asymptomatic and symptomatic neonatal infections in Vellore, India.

Authors:  Margaret H Libonati; Allison F Dennis; Sasirekha Ramani; Sarah M McDonald; Asmik Akopov; Ewen F Kirkness; Gagandeep Kang; John T Patton
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

9.  Identification of Rotavirus Strains Causing Diarrhoea in Children under Five Years of Age in Yogyakarta, Indonesia.

Authors:  Hera Nirwati; Mohamad Saifudin Hakim; Sri Aminah; Ida Bagus Nyoman Putra Dwija; Qiuwei Pan; Abu Tholib Aman
Journal:  Malays J Med Sci       Date:  2017-04-14

10.  Global seasonality of rotavirus disease.

Authors:  Manish M Patel; Virginia E Pitzer; Wladimir J Alonso; David Vera; Ben Lopman; Jacqueline Tate; Cecile Viboud; Umesh D Parashar
Journal:  Pediatr Infect Dis J       Date:  2013-04       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.